| Date Filed | Type | Description |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Litton Mark James (CEO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 885 shares
@ $12.51, valued at
$11.1k
Granted 400,000 options to buy
@ $9.91, valued at
$4M
|
|
| 08/19/2021 |
4
| Litton Mark James (COO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 867 shares
@ $14.45, valued at
$12.5k
Exercised 50,440 options to buy
@ $1.35, valued at
$68.1k
|
|
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2020 |
4
| Litton Mark James (COO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Converted 13,126 shares
@ $0
Converted 6,563 shares
@ $0
Converted 13,126 preferred shares
@ $0
Converted 6,563 preferred shares
@ $0 |
|
| 09/17/2020 |
3
| Litton Mark James (COO) has filed a Form 3 on Athira Pharma, Inc. |
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2018 |
4
| Litton Mark James (See Remarks) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 150,000 options to buy
@ $6.81, valued at
$1M
|
|
| 08/08/2018 |
3
| Litton Mark James (See Remarks) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC. |
| 06/05/2018 |
4
| Litton Mark James (Chief Business Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Sold 18,253 shares
@ $17.7409, valued at
$323.8k
Sold 4,474 shares
@ $18.2358, valued at
$81.6k
Exercised 22,727 options to buy
@ $0.99, valued at
$22.5k
|
|
| 02/21/2018 |
4
| Litton Mark James (Chief Business Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Granted 75,000 options to buy
@ $13.55, valued at
$1M
|
|
| 11/15/2017 |
4
| Litton Mark James (Chief Business Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Sold 16,519 shares
@ $10.8049, valued at
$178.5k
Exercised 16,519 options to buy
@ $1.65, valued at
$27.3k
|
|
| 10/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/14/2016 |
4
| Litton Mark James (Chief Business Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Exercised 25,000 options to buy
@ $0.385, valued at
$9.6k
|
|
| 06/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2016 |
4
| Litton Mark James (Chief Business Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC|
Txns:
| Sold 5,280 shares
@ $30.0555, valued at
$158.7k
Sold 19,720 shares
@ $30.049, valued at
$592.6k
Exercised 5,280 options to buy
@ $0.385, valued at
$2k
Exercised 19,720 options to buy
@ $0.385, valued at
$7.6k
|
|